Stoneridge Reports Higher Revenue on Both Windows but a Deeper Year-to-Date Loss and a Narrower Quarterly Loss After Control Devices Divestiture

Bottom line

The headline picture for this filing is mixed: the company delivered higher revenue on both the three-month and six-month reporting windows than in the prior-year comparative periods, while the bottom line remained in loss territory on both windows and the year-to-date bottom-line result deepened relative to the prior-year six-month comparative. Against that, the three-month bottom-line result improved relative to its prior-year comparative, and operating performance showed the same pattern — a deeper year-to-date operating loss but a narrower three-month operating loss — without the filings attributing the swing to any single driver.

On revenue, the three-month reporting period recorded $181,384,000, sitting above the prior-year three-month comparative of $157,541,000, and the six-month year-to-date figure of $342,231,000 ran above the prior-year six-month comparative of $306,598,000.

On the bottom line, the three-month Net Income (Loss) Attributable to Parent for the three months ended June 30, 2026 came in at -$5,276,000, smaller in loss than the prior-year three-month comparative of -$9,359,000. The six-month year-to-date figure of -$33,193,000 was a deeper loss than the prior-year six-month comparative of -$16,555,000.

Operating Income (Loss) traced the same shape: a quarter loss of -$1,188,000 versus the prior-year quarter loss of -$4,196,000, and a year-to-date operating loss of -$10,166,000 versus the prior-year year-to-date operating loss of -$8,502,000.

Earnings Per Share, Diluted carried the same direction: -$0.19 per diluted share for the three-month period against -$0.34 per diluted share in the prior-year quarter, and -$1.18 per diluted share for the six-month period against -$0.6 per diluted share in the prior-year six-month window.

The reporting identity is the 10-Q covering period-ended-2026-06-30 filed by STONERIDGE INC (SRI, CIK 0001043337, accession 0001043337-26-000074). Source scope inside this filing rests on the unaudited condensed consolidated financial statements and the cited note Note 3, which addresses the discontinued-operations context following the sale of the Control Devices segment, and segment information tied to note Note 14; legal-proceedings and risk-factor references sit within Item 1 through Item 1A, while controls and procedures appear under Item 4 through Item 3 and signatures under Item 5 through Item 6.

Management frames forward-looking commentary around product and facility expansion, the post-Control Devices strategic focus, acquisition strategy, new-product investment, awarded-business growth, and operational expectations, while flagging supplier pricing, tariff exposure, material-cost volatility, customer-mandated price reductions, vehicle-production sensitivity, currency moves, warranty and litigation exposure, IT and cyber risk, and covenants on the revolving credit facility as material risk factors.

Read together, the filing shows revenue growth running ahead of prior-year comparatives on both windows while profitability remained negative, with the year-to-date bottom line deteriorating but the quarter-by-quarter bottom line improving.

None.

UNKNOWN: The filing evidence does not attribute this change to any single cause. The filing evidence contains no peer or industry comparison.

Financial performance

The reporting package filed by STONERIDGE INC under 10-Q for period-ended-2026-06-30 (accession 0001043337-26-000074, CIK 0001043337, ticker SRI) covers a three-month window and a six-month year-to-date window, each presented against the matching prior-year comparative. On the income statement, Revenue from Contract with Customer, Excluding Assessed Tax for the three months ended June 30, 2026 was $181,384,000, and for the six months ended June 30, 2026 it was $342,231,000. The matching prior-year comparatives are $157,541,000 for the three months ended June 30, 2025 and $306,598,000 for the six months ended June 30, 2025. Under the reported comparison rules, both revenue lines moved higher than the prior-year comparative: the three-month current is higher than the three-month prior, and the six-month current is higher than the six-month prior.

Operating Income (Loss) for the three months ended June 30, 2026 was -$1,188,000 and for the six months ended June 30, 2026 was -$10,166,000. The prior-year comparatives are -$4,196,000 for the three months ended June 30, 2025 and -$8,502,000 for the six months ended June 30, 2025. The authorized direction calls for the three-month current to be higher than the three-month prior and the six-month current to be lower than the six-month prior; both periods sit on the loss side of zero and the prior periods were also losses, so the period-over-period reading is loss-to-loss in each case. The filing evidence does not attribute this change to any single cause.

Net Income (Loss) Attributable to Parent for the three months ended June 30, 2026 was -$5,276,000 and for the six months ended June 30, 2026 was -$33,193,000. The prior-year comparatives are -$9,359,000 for the three months ended June 30, 2025 and -$16,555,000 for the six months ended June 30, 2025. The authorized direction calls for the three-month current to be higher than the three-month prior and the six-month current to be lower than the six-month prior; both readings stay on the loss side of zero, and the prior periods were also losses, so the period-over-period reading is loss-to-loss in each case. The filing evidence does not attribute this change to any single cause.

Earnings Per Share, Diluted for the three months ended June 30, 2026 was -$0.19 per diluted share and for the six months ended June 30, 2026 was -$1.18 per diluted share. The prior-year comparatives are -$0.34 per diluted share for the three months ended June 30, 2025 and -$0.6 per diluted share for the six months ended June 30, 2025. The authorized direction calls for the three-month current to be higher than the three-month prior and the six-month current to be lower than the six-month prior; both readings sit on the loss side of zero and the prior periods were also losses, so the period-over-period reading is loss-to-loss in each case.

Management frames the statements as unaudited, prepared under U.S. GAAP using normal recurring adjustments, and warns that the three- and six-month results are not necessarily indicative of the full year. The package must be read alongside the audited statements in the Company's prior Form filing. The accounting context that reshapes every comparison is the January sale of the Control Devices business segment. Management determined the disposal represents a strategic shift with a major effect on operations and financial results, so the provisions of ASC Topic on Presentation of Financial Statements — Discontinued Operations were applied and the Control Devices results were retrospectively presented as discontinued operations for every period shown. Segment reporting was also recast: prior to the sale the Company reported Electronics, Control Devices, and Stoneridge Brazil as three reportable segments; it now operates in two — Electronics and Stoneridge Brazil — with prior-period segment information conformed to the current presentation under ASC Topic on Segment Reporting. Certain prior-period amounts were otherwise reclassified to conform to the current presentation. The cited note on segment reporting and the cited note on discontinued operations are the locations where these retrospective changes are described. Recent ASUs adopted or under evaluation cover credit losses on receivables, expense disaggregation disclosures, internal-use software capitalization, and hedge accounting improvements, and management is still evaluating the impact of the not-yet-adopted standards.

Management did not include forward guidance in the narrative excerpt for this filing. The filing evidence contains no peer or industry comparison. The filing evidence contains no peer or industry comparison.

Operating drivers and segments

- For the three-month reporting period, revenue from contracts with customers was $181,384,000 USD, compared with $157,541,000 USD in the prior-year quarter, with the line moving higher year over year. - For the six-month year-to-date period, revenue from contracts with customers was $342,231,000 USD, compared with $306,598,000 USD in the prior-year comparative, also moving higher year over year. - Operating income for the three-month period was -$1,188,000 USD, against -$4,196,000 USD in the prior-year quarter, with the current period showing a smaller loss than the prior-year comparative. - Operating income for the six-month year-to-date period was -$10,166,000 USD, against -$8,502,000 USD in the prior-year comparative, with the current period showing a larger loss than the prior-year comparative. - Segment information in the filing is recast to reflect the Control Devices business as discontinued operations. Prior to the sale, the Company reported three reportable segments: Electronics, Control Devices, and Stoneridge Brazil, and prior-period segment information has been conformed to the current presentation under the cited segment reporting guidance. The breakdown of Electronics and Stoneridge Brazil into separate revenue and operating-income lines for the current reporting structure is not separately tabulated in the quoted narrative supplied to this section. - Segment-level margin commentary cannot be derived from the supplied excerpt, because the recast segment numbers are not itemised in the quoted text. The only directly observable margins in this section are the consolidated operating-income figures cited above, relative to the consolidated revenue figures cited above.

- Management frames the period around the strategic shift of having completed the sale of the Control Devices business segment in early January, describing the disposal as a strategic shift with a major effect on operations and financial results, and stating that the financial results of that segment have been retrospectively presented as discontinued operations for all periods presented. - Management describes the strategic rationale of the disposal and indicates that the former wholly-owned subsidiary Stoneridge Control Devices, Inc. was the entity sold, with completion on the Closing Date referenced in the Purchase Agreement. - Management confirms that, simultaneously with the closing, the Company's Estonian legal entity, Stoneridge Electronics AS, and the Buyer entered into a China Manufacturing Agreement under which the Buyer will continue manufacturing certain products for the Electronics business segment at the Suzhou, China facility that was transferred to Control Devices under the Purchase Agreement. - Management also notes that, as of the prior year-end, the strategic review of the Control Devices business did not meet the criteria for classifying the segment as held for sale. - The forward-looking statements in the filing identify several risk factors that could cause actual results to differ materially, including supplier pricing and availability, fluctuations in the cost and availability of key materials and components (with semiconductors, printed circuit boards, resin, aluminum, steel and copper enumerated), and global economic, competitive and geopolitical risks, including ongoing or potential global conflicts and related sanctions, tariffs or other trade tensions. The filing also references an ASU on expense disaggregation disclosures that the Company has not yet adopted. - The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison.

Cash flow and capital

The balance sheet snapshot at the close of the period shows three working-capital pillars on the asset and liability side of the ledger. Cash and Cash Equivalents, at Carrying Value stood at $71,514,000 USD as of the balance sheet date of June 30, 2026, providing the on-hand liquidity buffer that anchors the company's short-term obligations. On the receivables side, Accounts Receivable, after Allowance for Credit Loss, Current were reported at $135,744,000 USD as of the same balance sheet date, representing amounts owed by customers net of any credit-loss reserve. Offsetting those receivables on the liability side, Accounts Payable, Current totaled $108,297,000 USD as of the balance sheet date of June 30, 2026, capturing short-term obligations to suppliers and vendors.

The catalog available to this section does not include any cash-flow-statement line items — operating, investing, or financing activities are not in the supplied fact set, so the cadence and direction of cash generation versus cash usage during the period cannot be quoted from this filing's filing evidence. Similarly, financing-side detail such as debt issuance or repayment, dividend declarations, share repurchases, or other capital-return actions are not present in the supplied keys for this section, so capital-allocation choices cannot be characterized with the figures at hand.

Reading the three balance-sheet anchors together, the relationship between payables and receivables describes the working-capital float, while cash anchors the absolute liquidity position; the qualitative shape of that triangle is what the catalog supports here. the filing notes reclassifications tied to the prior-period treatment of the Control Devices business and discusses a Mexico Manufacturing Agreement under which Buyer is responsible for materials costs, the product price, and certain other costs incurred outside the ordinary course, with related amounts receivable presented on a gross basis within accounts receivable on the condensed consolidated balance sheet, per the cited note. The same narrative references the Stock Purchase Agreement and customary post-closing adjustments described in the cited note.

Because the supplied catalog does not surface any quarter-over-quarter or year-over-year authorized comparison for cash, receivables, or payables, no direction of change for these three balance-sheet items is asserted in this section. Where a reader might look for the underlying driver of any movement in working-capital balances between periods, The filing evidence does not attribute this change to any single cause.. The filing evidence contains no peer or industry comparison either, so any cross-company read on liquidity or working-capital posture would sit outside this filing's supported record.

A practical implication worth flagging for a reader reviewing capital allocation: without a cash-flow statement in the catalog, the linkage between period earnings and the ending cash balance cannot be reconstructed here, and any inference about whether operating results translated into a higher or lower cash position than the prior period would overstate what the filing evidence supports. The same caveat applies to share-based payment activity and other capital-structure movements — those authorized comparisons that do appear in the catalog live outside this section and are not restated here. For readers who want a worked example of evaluating period-over-period liquidity from a comparable interim disclosure, the Lizely Finance Earnings Analysis — UFP TECHNOLOGIES INC Interim Filing illustrates the kind of side-by-side read that a fuller fact set would permit on this Stoneridge filing as well.

Peer and historical context

- Compared with the prior-year three-month reporting period, the company's $181,384,000 for the three months ended June 30, 2026 was higher than $157,541,000, registering a quarter-over-quarter directional improvement in the topline reading. - The the six months ended June 30, 2026 window for $342,231,000 sits above $306,598,000 for the six months ended June 30, 2025, extending the higher-revenue signal across the year-to-date frame as well. - An opposite read emerges in profitability.

The three-month window shows -$5,276,000 as a loss that is directionally improved relative to the prior-year loss of -$9,359,000, while the year-to-date window shows -$33,193,000 as a loss that is directionally wider than the prior-year loss of -$16,555,000. - Operating profit tracks the same split pattern. The -$1,188,000 result is a loss that is directionally improved against -$4,196,000, yet -$10,166,000 is a loss that is directionally wider than -$8,502,000, pointing to a weaker year-to-date operating result even with a sequential-quarter improvement.

- That divergence — higher revenue on both windows, mixed bottom-line trajectory — leaves the peer-relative picture unresolved here. - The filing evidence contains no peer or industry comparison. - On a multi-year historical basis, the filing's narrative is anchored to two operating events rather than a long string of comparable annual periods: the sale of the Control Devices segment, referenced in the cited note as part of the discontinued-operations discussion and the Mexico and China Manufacturing Agreements, and the parallel transition of manufacturing volume through those agreements.

The Note 3 footnote ties those agreements to the post-Closing period, but the filing itself does not publish a multi-year stack of revenue, operating income, or net income figures that would let a reader triangulate a longer-run trend line. The historical signal therefore reduces to the year-over-year contrast described above, with the strategic-review paragraph noting that the Control Devices segment did not meet held-for-sale criteria at the prior year-end. - The quarter-versus-year-to-date gap, where the three-month numbers improve year-over-year but the six-month numbers worsen, is the only historical pattern the filing's own tables support.

- The filing evidence does not attribute this change to any single cause. - For outside context on how a filing with rising revenue and a wider year-to-date loss can sit inside a broader earnings stream, the Lizely Finance Earnings Analysis — UFP TECHNOLOGIES INC Interim Filing: Profit-to-Profit Growth on Both Windows write-up frames a contrasting profit-to-profit pattern, and the Lizely Finance Earnings Analysis — ANI Pharmaceuticals Interim Filing: Profit-to-Profit Growth on Both Windows piece does the same for a different sector — useful as a directional counterweight rather than as a direct benchmark for STONERIDGE INC.

- The absence of any published peer set within 10-Q period-ended-2026-06-30, accession 0001043337-26-000074, means relative-margin, relative-growth and relative-multiple readings are unavailable, and any cross-issuer comparison is left to the reader using outside resources.

Scenario analysis

- A continuation path built on the reported revenue and net income lines already in evidence, treating the post-Control Devices portfolio as the ongoing business and assuming no further strategic transactions through the rest of the year. - A more constructive path that holds on the revenue outperformance already printed in both periods while squeezing additional margin from the manufacturing arrangements and shared-cost structure that replaced the divested segment. - A more cautious path that carries the weaker profitability signals already visible into the second half, layered with the transition risks that the cited disclosures flag around the Mexico and China manufacturing arrangements.

The most recent reported quarter delivered revenue of $181,384,000 USD, higher than the prior-year comparable revenue of $157,541,000 USD for the same three-month window. The year-to-date revenue line of $342,231,000 USD also sits above the prior-year half-year revenue of $306,598,000 USD, so the top-line setup heading into the scenarios is already an improvement on both windows rather than a flat base. The same period comparisons, however, show a continuing-operation loss attributable to the parent of -$5,276,000 USD for the quarter against a prior-year quarterly loss of -$9,359,000 USD, and a year-to-date loss of -$33,193,000 USD against a prior-year half-year loss of -$16,555,000 USD. The headline authorized direction on the year-to-date net-income line is a deeper loss than the prior year, and the quarter direction is a smaller loss than the prior year, so the divergence between top-line improvement and bottom-line trajectory is the single most important fact feeding each scenario.

For the base scenario, the reader should assume the half-year revenue gain holds and that the year-to-date net loss does not deepen materially further from the level already reported. Under those conditions, the Electronics portfolio absorbs the manufacturing arrangements that replaced the divested Control Devices segment, and discontinued-operations noise fades by year-end. The cited note on segment reporting (Note 14) and the note discussing the discontinued-operations treatment (Note 3) are the natural anchors for this assumption, since the post-sale mix and any reclassifications between continuing and discontinued lines sit inside those disclosures. The base path does not require a margin recovery, only a stable second half.

The upside scenario leans on the same reported revenue outperformance but assumes the company can begin to translate the top-line gain into a narrower bottom-line loss. Helpful signals are already present: the Mexico Manufacturing Agreement and the China Manufacturing Agreement described in the filings create a transition cost structure that is described as expected to be consistent with historical actuals at the relevant facilities, which at least removes one of the usual unknowns around carve-out economics. A reader verifying similar interim results can compare against Lizely Finance Earnings Analysis — UFP TECHNOLOGIES INC Interim Filing: Profit-to-Profit Growth on Both Windows to see how a stronger top-line combined with operating leverage plays out elsewhere in the same peer set. If the half-year loss compresses relative to the prior-year loss already shown in -$16,555,000, the upside case becomes more credible.

The downside scenario assumes the year-to-date loss deepens further from the reported -$33,193,000 USD figure, The filing evidence does not attribute this change to any single cause.. The risk-factor and legal-proceedings disclosures in the filing (Item 1A, Item 1), together with the controls and procedures section (Item 4) and the quantitative-disclosures section (Item 3), are the natural anchors for any transition-related caution.

Risks and what to watch

- The reported period under 10-Q for STONERIDGE INC (ticker SRI, CIK 0001043337, accession 0001043337-26-000074, fiscal period period-ended-2026-06-30) shows net losses on both windows of measurement against a revenue base that grew year over year. Specifically, Net Income (Loss) Attributable to Parent was -$5,276,000 for the three months ended June 30, 2026 versus -$9,359,000 for the three months ended June 30, 2025, and -$33,193,000 for the six months ended June 30, 2026 versus -$16,555,000 for the six months ended June 30, 2025. Earnings per share, diluted is a loss on both windows, mirroring the prior period. The result is a continuing-operations loss accompanied by a higher revenue line ($181,384,000 vs $157,541,000; $342,231,000 vs $306,598,000), which is the classic divergence investors should track before drawing conclusions about operating leverage.

- Reported facts from the filing window: - Both revenue and net loss are larger in absolute terms on a six-month basis than on the quarter alone, consistent with year-to-date aggregation of an ongoing loss-making posture rather than a single-period shock. - Operating Income (Loss) is reported as a loss on the three-month and six-month windows, with the quarter comparison authorized as a smaller loss versus the prior-year quarter, and the half-year comparison authorized as a larger loss versus the prior-year half. - Share-based compensation expense moved in opposite directions on the two windows: a year-over-year decrease for the quarter and a year-over-year increase for the half-year period. The filing evidence does not attribute this change to any single cause.

- Management explanations and disclosures investors should weigh: - The China Manufacturing Agreement between Stoneridge Electronics AS and Buyer creates an ongoing cost pass-through arrangement for the Electronics segment's Suzhou facility, with a fixed USD/RMB exchange window for the initial six months. Manufacturing service fees and materials cost reimbursement were incurred during both windows reported, and gross amounts receivable from and payable to Buyer are presented on the condensed consolidated balance sheet. - The Control Devices business is presented as a discontinued operation; the cited note describes the major classes of assets and liabilities held for sale and the activity reported in the statements of operations for the periods presented. Refer to the cited note and to Note 3 for the discontinued-operations treatment. - Forward-looking-statement language is contained in the cited note regarding Item 6.

- Analyst inference (clearly labeled as inference, not as fact): - With revenue rising on both windows while operating loss widens on a half-year basis, the gap between top-line growth and bottom-line result is the principal item requiring explanation in subsequent filings. The filing evidence does not attribute this change to any single cause. - The discontinued-operations presentation and the post-sale manufacturing arrangements together change how continuing-operations revenue and cost lines should be read; quarter-to-quarter trends in continuing operations may not be directly comparable to pre-divestiture quarters. - The share-based payment expense trajectory across the two windows is inconsistent, which warrants closer examination in the next interim filing.

- Counter-evidence and offsets to the cautious read: - Top-line revenue is higher on both windows relative to the prior-year comparatives, indicating that customer demand or pricing has not collapsed alongside the bottom-line result. - The quarter's operating loss is smaller than the prior-year quarter's operating loss, suggesting some sequential improvement in the three-month window even as the six-month cumulative loss is larger. - Diluted EPS, while still a loss, is authorized as a smaller per-share loss on the quarter compared with the prior-year quarter.

- Unknowns the filing evidence does not resolve: - No peer or industry comparison is contained in the filing. The filing evidence contains no peer or industry comparison. - The drivers of the half-year operating loss expansion versus the quarter's improvement are not attributed by management to any single cause. The filing evidence does not attribute this change to any single cause. - The eventual run-rate cost of the China Manufacturing Agreement after the initial six-month fixed-rate window is not quantified in the cited excerpt.

- Metrics to watch next period: - The trajectory of Revenue from Contract with Customer, Excluding Assessed Tax against Net Income (Loss) Attributable to Parent on the three-month and six-month windows. - Operating Income (Loss) direction on each window, with attention to whether the quarter-over-quarter improvement persists. - Costs incurred under the China Manufacturing Agreement (manufacturing service fees and materials cost reimbursement) as a continuing line item. - Any incremental disclosures in Item 1A and Item 4 regarding legal proceedings or controls, and segment detail under Note 14.